Regend Therapeutics
Clinical trials sponsored by Regend Therapeutics, explained in plain language.
-
Stem cell shot tested for scarred lungs
Disease control Not yet recruitingThis is a very early study to check if a new stem cell treatment is safe for people with idiopathic pulmonary fibrosis (IPF), a serious lung scarring disease. It will involve 12 participants who will receive the treatment by IV infusion. The main goal is to see if the treatment c…
Phase: EARLY_PHASE1 • Sponsor: Regend Therapeutics • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
First-in-Human trial tests Lung-Regenerating stem cells for COPD
Disease control Not yet recruitingThis is a very early study to test the safety of a new cell therapy called REGEND007 for people with COPD. The therapy uses special stem cells from the airways that may help repair damaged lung tissue. Researchers will give the cells through an IV to 12 participants and closely m…
Phase: EARLY_PHASE1 • Sponsor: Regend Therapeutics • Aim: Disease control
Last updated Mar 11, 2026 14:54 UTC